SDHB mutations are strongly associated with extra-adrenal sympathetic paragangliomas with an increased risk of metastatic disease, and less frequently, with Pheos and parasympathetic PGLs (Andrews et al., 2018). The gene discussed is SDHB; the disease is metastatic neoplasm.